| Date | Document |
|---|---|
| 11/06/2021 | Secondary Trading Notice |
| 11/06/2021 | Application for quotation of securities - RHT |
| 04/06/2021 | Resignation of CEO & Management Changes |
| 24/05/2021 | Filing of Patent Application |
| 17/05/2021 | R&D Update - Molecular Medicine ASO Project |
| 29/04/2021 | Appendix 4C - quarterly |
| 08/04/2021 | Appointment of CFO & Company Secretary |
| 09/03/2021 | Change of Director's Interest Notice |
| 09/03/2021 | Secondary Trading Notice & Appendix 2A |
| 26/02/2021 | Half Yearly Report and Accounts |
| 24/02/2021 | HepaFat-AI receives CE Marking |
| 18/02/2021 | HepaFat-AI Receives TGA Approval |
| 17/02/2021 | Trading Halt |
| 17/02/2021 | Pause in Trading |
| 28/01/2021 | Appendix 4C - quarterly |
| 12/01/2021 | Secondary Trading Notice & Appendix 2A |